Filtricine, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Filtricine, Inc. is a biotechnology research company focused on food-based approaches to treat cancer and metabolic diseases. It is based in Sunnyvale, California, and originated as a spinout from Prof. Michael Snyder’s lab at Stanford University School of Medicine. The company has conducted a small-scale clinical trial in prostate cancer patients at Stanford, reporting promising results. Its current initiative involves developing a human version of the TND diet, branded as Tality, to be used as a medical food for cancer management. This places Filtricine within the medical foods and therapeutic nutrition space targeting oncology and metabolic conditions. Public updates indicate ongoing work to translate the dietary concept into clinically applicable products.